Dr. Phil Gold made Canadian medical history in 1965—and now it’s official. Forty-five years after he and his colleague Dr. Samuel Freedman discovered the carcinoembryonic antigen (CEA)—which, as the first clinically useful human tumour marker, revolutionized the diagnosis and management of cancer—Gold is being inducted into the Canadian Medical Hall of Fame. He is professor of medicine, physiology and oncology in McGill’s Faculty of Medicine, and executive director of the Clinical Research Centre at the Montreal General Hospital.
“The relevance of Dr. Gold’s discovery over four decades ago stands today as an indelible testament to the value of research,” says Dr. Vassilios Papadopoulos, Director of the Research Institute (RI) at the MUHC. “He is a trusted friend to his colleagues, an invaluable contributor to many RI committees and a role model for young investigators.”